EDK
Editome Disease Knowledgebase
| Enzyme | ADAR3 |
|---|---|
| Full Name | Adenosine deaminase, RNA specific B2 |
| Location | Chr10:1177313..1737476 |
| Ensembl | ENSG00000185736 |
| Aliases | ADARB2;DRABA2;RED2 |
| Disease | Species | Regulator | Expression/Aberrance | Target | Target Function | Regulation | Editing-Level | Relationship | Correlation | Editing Effect | Phenotype | Editing-Dependent | PMID |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glioblastoma | Human | NA | Increase | GRIA2 | Receptor for glutamate that functions as a ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Deficiency of Glur2 editing may lead to nervous disease. | increased expression of ADAR3 decreases Q/R site of GRIA2 editing in nearly all the tumors compared to adjacent tissue. | Decreased | Correlated | Positive | NA | Affect Glioblastoma | Yes | |
| Astrocytomas | Human | NA | Increase | GRIA2 | Receptor for glutamate that functions as a ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Deficiency of Glur2 editing may lead to nervous disease. | Overexpression of ADAR3 in astrocyte and astrocytoma cell lines inhibits RNA editing at the Q/R site of GRIA2. | Decreased | Correlated | Positive | ADAR3 inhibits editing of the glutamate receptor in astrocytes, suggesting that ADAR3 may regulate neuronal RNA editing and contribute to ALS physiology. | Affect Astrocytomas | Yes |